• We’re currently investigating an issue related to the forum theme and styling that is impacting page layout and visual formatting. The problem has been identified, and we are actively working on a resolution. There is no impact to user data or functionality, this is strictly a front-end display issue. We’ll post an update once the fix has been deployed. Thanks for your patience while we get this sorted.

Breakthrough: Indevus gel protects women from AIDS virus

moshquerade

moshquerade

No Lifer
and men just the same?


Indevus gel protects women from AIDS virus: research

Mon Feb 9, 9:06 am ET WASHINGTON (Reuters) ?

An Indevus Pharmaceuticals gel formulated to protect women from the virus that causes AIDS appeared to protect about a third of them from infection -- the first time a so-called microbicide has been shown to work, researchers told a conference in Montreal. Dr. Salim Abdool Karim of the Center for the AIDS Program of Research in South Africa and colleagues said the trial of 3,000 women showed the gel may have protected 30 percent of the women from infection.
Click to expand...
http://news.yahoo.com/s/nm/20090209/ts_nm/us_aids_drug
 
seems a little arrogant to be exposing patients intentionally to the virus to see if the transmission can be prevented.
 
Originally posted by: sao123
seems a little arrogant to be exposing patients intentionally to the virus to see if the transmission can be prevented.
Click to expand...

You really don't understand how this works do you? They take a group of high risk people and put some of them on a drug or in this case a gel.

Then they evaluate the results. It takes HUGE sample size but it works. No one was purposely exposed. It was just high risk individuals engaging in high risk behavior.
 
More info:
http://www.bizjournals.com/bos...2009/02/09/daily5.html

The National Institutes of Health has finished a study that found that women who received a vaginal microbial gel called PRO 200, made by Indevus, were 30 percent less likely to contract HIV than women who did not receive the gel. This is the first trial to suggest that any microbicide may prevent male-to-female transmission of HIV, according to Lexington-based Indevus. The study included 3,100 women and was conducted at seven clinical centers in Malawi, Zimbabwe, South Africa, Zambia and the U.S.. The women in the study were also given access to free condoms and safer-sex information. A second study, involving 10,000 women, is expected to be completed later this year.

?We are extremely excited with the results of this trial?, Indevus CEO Glenn Cooper said in a statement. ?Though not conclusive, these results provide encouragement that PRO 2000 may offer a female-controlled method that can be used to protect against the sexual transmission of HIV.?

Indevus is a pharmaceutical company specializing in products to treat conditions in urology and endocrinology. The company currently has five products on the market, including drugs for overactive bladder and prostate cancer.
Click to expand...
 
Originally posted by: chuckywang
What a slap in the face of God
Click to expand...

^ What an ignorant thing to say. Do you WANT people to have AIDS? If you are argueing the whole "gods will be done" thing then its gods will to have things to prevent it. Religious zealots FTL
 
Originally posted by: RadiclDreamer
Originally posted by: chuckywang
What a slap in the face of God
Click to expand...

^ What an ignorant thing to say. Do you WANT people to have AIDS? If you are argueing the whole "gods will be done" thing then its gods will to have things to prevent it. Religious zealots FTL
Click to expand...

I am willing to bet that comment was laced with lots of sarcasm......
 
Originally posted by: Crono
More info:
http://www.bizjournals.com/bos...2009/02/09/daily5.html

The National Institutes of Health has finished a study that found that women who received a vaginal microbial gel called PRO 200, made by Indevus, were 30 percent less likely to contract HIV than women who did not receive the gel. This is the first trial to suggest that any microbicide may prevent male-to-female transmission of HIV, according to Lexington-based Indevus. The study included 3,100 women and was conducted at seven clinical centers in Malawi, Zimbabwe, South Africa, Zambia and the U.S.. The women in the study were also given access to free condoms and safer-sex information. A second study, involving 10,000 women, is expected to be completed later this year.

?We are extremely excited with the results of this trial?, Indevus CEO Glenn Cooper said in a statement. ?Though not conclusive, these results provide encouragement that PRO 2000 may offer a female-controlled method that can be used to protect against the sexual transmission of HIV.?

Indevus is a pharmaceutical company specializing in products to treat conditions in urology and endocrinology. The company currently has five products on the market, including drugs for overactive bladder and prostate cancer.
Click to expand...
Click to expand...

And this didn't have anything at all to do with the results by chance? :roll:
 
Originally posted by: SunnyD
Originally posted by: Crono
More info:
http://www.bizjournals.com/bos...2009/02/09/daily5.html

The National Institutes of Health has finished a study that found that women who received a vaginal microbial gel called PRO 200, made by Indevus, were 30 percent less likely to contract HIV than women who did not receive the gel. This is the first trial to suggest that any microbicide may prevent male-to-female transmission of HIV, according to Lexington-based Indevus. The study included 3,100 women and was conducted at seven clinical centers in Malawi, Zimbabwe, South Africa, Zambia and the U.S.. The women in the study were also given access to free condoms and safer-sex information. A second study, involving 10,000 women, is expected to be completed later this year.

?We are extremely excited with the results of this trial?, Indevus CEO Glenn Cooper said in a statement. ?Though not conclusive, these results provide encouragement that PRO 2000 may offer a female-controlled method that can be used to protect against the sexual transmission of HIV.?

Indevus is a pharmaceutical company specializing in products to treat conditions in urology and endocrinology. The company currently has five products on the market, including drugs for overactive bladder and prostate cancer.
Click to expand...
Click to expand...

And this didn't have anything at all to do with the results by chance? :roll:
Click to expand...

Exactly.

Why is it that every study I read that gets posted here is always riddled with the most obvious gaps in logic.
 
Originally posted by: Kev
Why is it that every study I read that gets posted here is always riddled with the most obvious gaps in logic.
Click to expand...

Because *all* studies are riddled with obvious gaps in logic?
 
You must log in or register to reply here.

TRENDING THREADS

Back
Top